Advertisement

Topics

PubMed Journals Articles About "Vardenafil Levitra BAY38 9456 Erectile Dysfunction" RSS

18:31 EDT 16th October 2018 | BioPortfolio

Vardenafil Levitra BAY38 9456 Erectile Dysfunction PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Vardenafil Levitra BAY38 9456 Erectile Dysfunction articles that have been published worldwide.

More Information about "Vardenafil Levitra BAY38 9456 Erectile Dysfunction" on BioPortfolio

We have published hundreds of Vardenafil Levitra BAY38 9456 Erectile Dysfunction news stories on BioPortfolio along with dozens of Vardenafil Levitra BAY38 9456 Erectile Dysfunction Clinical Trials and PubMed Articles about Vardenafil Levitra BAY38 9456 Erectile Dysfunction for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vardenafil Levitra BAY38 9456 Erectile Dysfunction Companies in our database. You can also find out about relevant Vardenafil Levitra BAY38 9456 Erectile Dysfunction Drugs and Medications on this site too.

Showing "Vardenafil Levitra BAY38 9456 Erectile Dysfunction" PubMed Articles 1–25 of 3,200+

Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of Vardenafil hydrochloride.

Vardenafil hydrochloride (VAR) is an erectile dysfunction treating drug. VAR has a short elimination half-life (4-5 h) and suffers low oral bioavailability (15%). This work aimed to explore the dual potential of VAR-dendrimer complexes as drug release modulators and oral bioavailability enhancers. VAR-dendrimer complexes were prepared by solvent evaporation technique using four dendrimer generations (G4.5, G5, G5.5 and G6) at three concentrations (190 nM, 380 nM and 950 nM). The systems were evaluat...


Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.

Clinical study and practice data have shown sildenafil improves sexual function in men with erectile dysfunction (ED). However, some men treated with placebo in double-blind, placebo-controlled sildenafil studies also report improved erectile function as measured by International Index of Erectile Function (IIEF)-Erectile Function Domain (EFD) scores.

Penile erectile strength measurement band for differentiation and classification of erectile dysfunction.

To study the clinical application value of the penile erectile strength measurement (PESM) band in the differentiation of psychogenic from organic erectile dysfunction (ED).


Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study.

Erectile dysfunction (ED) is an increasingly common complaint among men aged

Exercise training causes a partial improvement through increasing testosterone and eNOS for erectile function in middle-aged rats.

Aging changes the balance of sex hormones and causes endothelial dysfunction in the penis, both of which are important determinants of erectile dysfunction (ED). The purpose of this study was to evaluate whether exercise training could protect against erectile dysfunction by increasing serum testosterone and penile eNOS levels in aging rats.

Erectile dysfunction and psychological status in infertile males.

To investigate the relationship of erectile dysfunction (ED) with psychological factors in male patients with infertility.

Erectile Dysfunction: AUA Guideline.

The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction.

Erectile Dysfunction and Lower Urinary Tract Symptoms.

In the past years, the relationship between lower urinary tract symptoms and erectile dysfunction has been widely explored. The aim of our systematic review is to summarize the published evidence over the past year on lower urinary tract symptoms (LUTS) and erectile dysfunction (ED).

Animal models of erectile dysfunction: Establishment and evaluation.

At present, the study of erectile dysfunction depends heavily on animal models, but the differences in anatomy and physiology of currently used animals make it difficult to exceed the limitations on the experiment. In order to make the results of experiments more applicable and beneficial to the public, it is essential to establish most suitable animal models for the study of the sexual function of humans. Moreover, a consensus has not yet been reached on the methods of detecting and evaluating the erectile...

Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?

The aim of our study was to assess the correlation between serum endocan level and erectile dysfunction (ED).

Chronic periodontitis is associated to erectile dysfunction. A case-control study in european population.

To determine the association between chronic periodontitis and erectile dysfunction adjusting for biochemical markers and other co-morbidities.

Erectile dysfunction treated with intracavernous stem cells: A promising new therapy?

In the past decades, great interest has been shown in the development of new therapies for erectile dysfunction. Stem cell therapy has generated promising results in numerous preclinical trials in animal models, which is why has led to the development of the first clinical trials in humans. The main cause involved in the pathophysiology of erectile dysfunction is vascular damage related to endothelial and neuronal injury. The interest in stem cell therapy is justified by their capability to differentiate in...

Lipomers (Lipid-polymer Hybrid Particles) of Vardenafil Hydrochloride: a Promising Dual Platform for Modifying the Drug Release Rate and Enhancing Its Oral Bioavailability.

Vardenafil hydrochloride is commonly used for the curing of erectile dysfunction. VAR suffers certain limitations: (i) short elimination half-life (4-5 h), (ii) low aqueous solubility (0.11 mg/mL), (iii) susceptibility to extensive first-pass metabolism and drug efflux transporters (P-glycoprotein), and (iv) limited (15%) oral bioavailability. The current study focused on the development of VAR lipomers as promising modified release systems able to enhance oral bioavailability. VAR-lipomers (lipid-polymer...

Comparison of the effects of extracorporeal shock wave therapy and a vacuum erectile device on penile erectile dysfunction: a randomized clinical trial: Retraction.

Blockade of Toll-Like Receptor 4 Attenuates Erectile Dysfunction in Diabetic Rats.

While increased toll-like receptor (TLR)4 activity may contribute to the pathophysiology of vascular diseases, the molecular mechanisms disrupted by this receptor in the vasculature are still poorly understood. Additionally, it is unknown if TLR4 mediates erectile dysfunction (ED) during diabetes.

Assessment of the erectile function and patients' perception of improvement in Spanish patients with erectile dysfunction.

This study has been carried out to assess the hardness of erection and the perception of improvement in erectile function with the treatments received during the last month.

Phenolic-rich extracts of Eurycoma longifolia and Cylicodiscus gabunensis inhibit enzymes responsible for the development of erectile dysfunction and are antioxidants.

Herbs have been used from ages to manage male sexual dysfunction. Hence, this study sought to investigate the effects of Eurycoma longifolia (EL) and Cylicodiscus gabunensis (CG) stem bark extracts on some enzymes implicated in erectile dysfunction in vitro.

High Prevalence of Erectile Dysfunction in Diabetic Men With Depressive Symptoms: A Meta-Analysis.

Erectile dysfunction (ED) may be common among diabetic men with depressive symptoms (DS), but its prevalence is still debated.

Treatment for erectile dysfunction among older men in Northern Ireland.

Erectile dysfunction is common among older men; however, diagnosis and treatment compared to reported prevalence is low. We aim to identify the degree to which older men are offered treatment for the condition and determine the level of unmet need within Northern Ireland (NI).

The Effects of Nocturnal Blood Pressure Paterns and Autonomic Alterations on Erectile Functions in Patients with Hypertension.

Hypertension (HT) is known to be of the main risk factors for erectile dysfunction (ED). But non-dipping (

Contrast-enhanced ultrasonography in the diagnosis of venous erectile dysfunction.

To investigate the effect and safety of contrast-enhanced ultrasonography (CEUS) in the diagnosis of venous erectile dysfunction (VED).

Association between use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs and erectile dysfunction: A systematic review.

There are various etiologies of erectile dysfunction (ED), including endothelial dysfunction, atherosclerosis, and chronic inflammation. Aspirin has a protective role against endothelial dysfunction and atherosclerosis, whease all non-steroidal anti-inflammatory drugs (NSAIDs) are known for their anti-inflammatory properties. However, association between the use of aspirin or non-aspirin NSAIDs and ED is controversial. Therefore, we reviewed this relationship.

Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis.

Some studies have reported that exposure to depression increases the risk of erectile dysfunction (ED), whereas others have observed no association. Moreover, additional studies have reported that exposure to ED increases the risk of depression.

Sexual life quality of spinal cord-injured men receiving pharmacological treatment for erectile dysfunction and their partners.

To assess the quality of sexual life reported by spinal cord-injured men treated with oral drugs for erectile dysfunction (ED) and their female partners.

Focused low-intensity extracorporeal shock wave therapy for erectile dysfunction: Preliminary observation of 32 cases.

To make a preliminary investigation on the safety and efficacy of focused low-intensity extracorporeal shock wave therapy (LI-ESWT) in the treatment of erectile dysfunction (ED).


Advertisement
Quick Search
Advertisement
Advertisement